Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT05984953 Completed - Clinical trials for Coronary Artery Disease

Rosuvastatin and Evolocumab for Coronary Artery Disease

Yellow V
Start date: August 1, 2013
Phase:
Study type: Observational

The aim of the retrospective study is to characterize the molecular mechanisms responsible for the effect of statins and evolocumab in patients with stable coronary artery disease. The research team will retrieve and review intravascular imaging and gene expression data previously collected in the catheterization laboratory during the following time-period: 8/1/2013-4/14/2015 and 5/4/2021 - 10/28/2022.

NCT ID: NCT05982366 Completed - Clinical trials for Coronary Artery Disease

Feasibility and Safety of the Routine Distal Transradial Approach

ANTARES
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The distal transradial approach (dTRA) via the anatomical snuffbox is hypothesized to be more beneficial than the conventional transradial access (cTRA) in patients undergoing coronary procedures. This prospective single-center randomized trial was designed to investigate the safety, efficacy, and various ultrasound parameters of dTRA.

NCT ID: NCT05981911 Recruiting - Clinical trials for Coronary Artery Disease

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

IRIS Skypoint
Start date: December 30, 2023
Phase:
Study type: Observational

The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.

NCT ID: NCT05980364 Completed - Clinical trials for Have a Diagnosis of Coronary Artery Disease

Cardiac Rehabilitation in Coronary Artery Diseases

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

Cardiac rehabilitation is approaches that focus on accelerating the recovery process of patients after a cardiac event, improving their physical, psychological and social conditions, and controlling risk factors. Cardiac rehabilitation is known to be an effective and cost-effective approach in the secondary prevention of cardiovascular diseases, most of which are caused by preventable risks. Ischemic heart diseases, one of the cardiovascular diseases, are responsible for 16% of total deaths in the world and have increased significantly since 2000, causing 8.9 million deaths in 2019. When coronary artery diseases cannot be prevented, the basic approach should be to ensure the individual's compliance with treatment and healthy lifestyle behaviors, and to increase the quality of life and life span. For this reason, the aim of the study is to examine the effects of technology-based education structured according to the health promotion model in cardiac rehabilitation on healthy lifestyle behaviors, health fatalism and risk knowledge level. Question 1. Does technology-based education structured according to the health promotion model affect the healthy lifestyle behaviors score? Question 2. Does technology-based education structured according to the health promotion model affect the health fatalism score? Question 3. Does technology-based education structured according to the health promotion model affect the cardiovascular disease risk factors knowledge level score?

NCT ID: NCT05978726 Completed - Clinical trials for Coronary Heart Disease

Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR

Start date: July 1, 2017
Phase:
Study type: Observational

Coronary microvascular dysfunction (CMD) is increasingly recognized as an important indicator for long-term prognosis in patients with acute myocardial infarction (AMI). The angiography-derived index of microcirculatory resistance (angio-IMR) is a novel guidewire-free measure for CMD in patients with AMI. Ticagrelor has recently been suggested to have additional benefits on coronary microcirculation beyond its antiplatelet effect. This study was designed to compare the protective effects of ticagrelor and clopidogrel on CMD and prognostic impact in patients with AMI, using the angio-IMR as a novel assessment tool.

NCT ID: NCT05977842 Recruiting - Clinical trials for Coronary Artery Disease

Drug-coated Balloon in de Novo Chronic Total Occlusions

CTO-DENOVO
Start date: January 31, 2024
Phase:
Study type: Observational

The CTO-DENOVO study is a multicenter registry of consecutive patients with de novo CTO undergoing successful CTO recanalization with the use of DCB-only strategy. The primary endpoint is target lesion failure at 6 months. The secondary endpoints are: 1) late lumen loss on follow-up angiography, and 2) minimal lumen area on follow-up intravascular ultrasound.

NCT ID: NCT05975567 Not yet recruiting - Clinical trials for Coronary Artery Disease

Deploying Novel Imaging Modalities Towards a Three-dimensional (3D) CARDIOvascular PATHology

3D-CARDIOPATH
Start date: September 1, 2023
Phase:
Study type: Observational

The goal of the 3D-CARDIOPATH study is to investigate the potential added value of emerging 3D imaging modalities by imaging ex vivo cardiac specimens (diseased coronary arteries, calcific aortic valves, and thrombotic materials) in 3D. Specifically, 20 cadaveric coronary artery segments with advanced atherosclerosis will be received from 10 patients with SCD. These segments will first be scanned with intravascular imaging modalities, namely optical coherence tomography (OCT) and intravascular ultrasound (IVUS), and then with micro-computed tomography (micro-CT) and light sheet fluorescence microscopy (LSFM). Additionally, 30 thrombotic specimens aspirated from patients with ST-elevated myocardial infarction, will also be scanned using micro-CT. Finally, 30 surgically removed aortic valves will undergo scanning with micro-CT and LSFM. Traditional histopathological assessment will also be performed on the scanned specimens. Patient laboratory profiles, past medical histories, demographic characteristics, and therapeutic management will be recorded, where applicable.

NCT ID: NCT05969665 Recruiting - Physical Activity Clinical Trials

Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors

Start date: February 7, 2024
Phase: N/A
Study type: Interventional

The study aims to assess the effect of smart watches and continuous glucose measuring devices on cardiovascular risk factors.

NCT ID: NCT05966662 Recruiting - Clinical trials for Coronary Artery Disease

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Start date: December 8, 2023
Phase: N/A
Study type: Interventional

This investigational device exemption (IDE) study is to assess the safety and effectiveness of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2+ 2Hz Coronary IVL Catheter to treat de novo, calcified, stenotic, coronary lesions prior to stenting.

NCT ID: NCT05965882 Recruiting - Clinical trials for Cardiovascular Diseases

A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )

Start date: June 2016
Phase:
Study type: Observational

The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.